117 related articles for article (PubMed ID: 15701587)
1. Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
Vissers WH; Roelofzen J; De Jong EM; Van Erp PE; Van de Kerkhof PC
Eur J Dermatol; 2005; 15(1):13-7. PubMed ID: 15701587
[TBL] [Abstract][Full Text] [Related]
2. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
3. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
Vissers WH; Arndtz CH; Muys L; Van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2004 May; 150(5):852-9. PubMed ID: 15149496
[TBL] [Abstract][Full Text] [Related]
4. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Vissers WH; Berends M; Muys L; van Erp PE; de Jong EM; van de Kerkhof PC
Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis.
Vissers WH; Muys L; Erp PE; de Jong EM; van de Kerkhof PC
Eur J Dermatol; 2004; 14(4):216-20. PubMed ID: 15319153
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
[TBL] [Abstract][Full Text] [Related]
7. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
Bovenschen HJ; Langewouters AM; van de Kerkhof PC
Am J Clin Dermatol; 2010; 11(5):343-50. PubMed ID: 20553063
[TBL] [Abstract][Full Text] [Related]
8. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Bovenschen HJ; Gerritsen WJ; van Rens DW; Seyger MM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 2007 Feb; 298(9):457-63. PubMed ID: 17136563
[TBL] [Abstract][Full Text] [Related]
9. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
10. Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment.
Bovenschen HJ; Vissers WH; Seyger MM; van de Kerkhof PC
Acta Derm Venereol; 2005; 85(2):113-7. PubMed ID: 15823902
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
Liao YH; Jee SH; Sheu BC; Huang YL; Tseng MP; Hsu SM; Tsai TF
Br J Dermatol; 2006 Aug; 155(2):318-24. PubMed ID: 16882169
[TBL] [Abstract][Full Text] [Related]
12. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Bovenschen HJ; Erceg A; Van Vlijmen-Willems I; Van De Kerkhof PC; Seyger MM
J Dermatolog Treat; 2007; 18(1):32-9. PubMed ID: 17365265
[TBL] [Abstract][Full Text] [Related]
13. The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
Vissers WH; van Duijnhoven M; van Erp PE; de Jong EM; van de Kerkhof PC
J Dermatolog Treat; 2008; 19(6):344-50. PubMed ID: 19016104
[TBL] [Abstract][Full Text] [Related]
14. The role of lesional T cells in recalcitrant psoriasis during infliximab therapy.
Bovenschen HJ; Van De Kerkhof PC; Gerritsen WJ; Seyger MM
Eur J Dermatol; 2005; 15(6):454-8. PubMed ID: 16280298
[TBL] [Abstract][Full Text] [Related]
15. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
Horrocks C; Holder JE; Berth-Jones J; Camp RD
Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
[TBL] [Abstract][Full Text] [Related]
16. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
Bovenschen HJ; Otero ME; Langewouters AM; van Vlijmen-Willems IM; van Rens DW; Seyger MM; van de Kerkhof PC
Br J Dermatol; 2007 Feb; 156(2):263-70. PubMed ID: 17223865
[TBL] [Abstract][Full Text] [Related]
17. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
[TBL] [Abstract][Full Text] [Related]
18. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples.
Carrascosa JM; Tapia G; Bielsa I; Fuente MJ; Ferrandiz C
J Cutan Pathol; 2007 Oct; 34(10):769-76. PubMed ID: 17880582
[TBL] [Abstract][Full Text] [Related]
19. Perforin expression is upregulated in the epidermis of psoriatic lesions.
Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.
Langewouters AM; van Erp PE; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 2008 Mar; 300(3):107-13. PubMed ID: 18157542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
